Susquehanna International Group, LLP Aravive, Inc. Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.11 - $0.22 $1,775 - $3,550	-16,139 Reduced 38.84%	25,413 $3,000
Q3 2023 Nov 14, 2023	BUY	$0.11 - $1.76 $4,570 - $73,131	41,552 New	41,552 $5,000
Q1 2023 May 16, 2023	BUY	$1.29 - $2.46 $169,809 - $323,822	131,635 New	131,635 $263,000
Q2 2022 Aug 15, 2022	SELL	$0.93 - $1.9 $51,954 - $106,143	-55,865 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.85 - $2.75 $66,986 - $99,574	36,209 Added 184.21%	55,865 $108,000
Q4 2021 Feb 14, 2022	BUY	$2.19 - $4.07 $19,898 - $36,980	9,086 Added 85.96%	19,656 $43,000
Q3 2021 Nov 15, 2021	SELL	$3.67 - $5.8 $81,936 - $129,490	-22,326 Reduced 67.87%	10,570 $39,000
Q2 2021 Aug 11, 2021	BUY	$4.65 - $6.42 $152,966 - $211,192	32,896 New	32,896 $197,000
Q1 2021 May 17, 2021	SELL	$5.11 - $9.24 $129,610 - $234,363	-25,364 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.36 - $6.51 $62,962 - $94,010	14,441 Added 132.21%	25,364 $143,000
Q3 2020 Nov 16, 2020	SELL	$4.7 - $12.06 $377,607 - $968,924	-80,342 Reduced 88.03%	10,923 $51,000
Q1 2020 May 15, 2020	BUY	$3.5 - $13.77 $175,577 - $690,772	50,165 Added 122.06%	91,265 $526,000
Q4 2019 Feb 14, 2020	BUY	$6.21 - $14.02 $59,249 - $133,764	9,541 Added 30.23%	41,100 $562,000
Q3 2019 Nov 14, 2019	BUY	$5.2 - $8.68 $164,106 - $273,932	31,559 New	31,559 $237,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.